4//SEC Filing
Dumesnil Simon 4
Accession 0001213900-24-019217
CIK 0001841330other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 9:45 PM ET
Size
6.0 KB
Accession
0001213900-24-019217
Insider Transaction Report
Form 4
Dumesnil Simon
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-01+7,500→ 7,500 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001875691
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 9:45 PM ET
- Size
- 6.0 KB